
0:00
22:58
Plasma cell dyscrasia-driven hypercalcemia stems from uncoupled bone remodeling via RANKL upregulation, MIP-1alpha, and osteoclast activation rather than PTHrP mediation. We break down the diagnostic pathway distinguishing multiple myeloma from rare paraneoplastic causes, serum and urine protein electrophoresis, free light chain kinetics, and urgent therapeutic interventions using aggressive volume expansion, zoledronic acid, denosumab, and targeted clone-directed antimyeloma therapy.
Weitere Episoden von „Endocrine Deep Dives“



Verpasse keine Episode von “Endocrine Deep Dives” und abonniere ihn in der kostenlosen GetPodcast App.








